BioCentury | Dec 14, 2017
Translation in Brief

STUBbing out thrombosis

Patients with chronic kidney disease are at a higher risk of thrombosis, especially following surgery and dialysis, but are also at a higher risk of bleeding than healthy individuals, making standard antithrombotic therapies dangerous. A...
BioCentury | Aug 2, 2012
Tools & Techniques

Drug design on the fly

Researchers at the University of California, San Francisco and Mount Sinai School of Medicine have used a Drosophila cancer model to identify small molecule kinase inhibitors that target a discrete spectrum of kinases. 1 The...
BioCentury | Feb 19, 2009
Targets & Mechanisms

Beta-blocking wounds

Researchers at the University of California, Davis think they may have identified a new indication for β-blockers: wound healing. 1 Although the safety profile of the drugs in cardiovascular disorders provides an incentive to repurpose...
Items per page:
1 - 3 of 3
BioCentury | Dec 14, 2017
Translation in Brief

STUBbing out thrombosis

Patients with chronic kidney disease are at a higher risk of thrombosis, especially following surgery and dialysis, but are also at a higher risk of bleeding than healthy individuals, making standard antithrombotic therapies dangerous. A...
BioCentury | Aug 2, 2012
Tools & Techniques

Drug design on the fly

Researchers at the University of California, San Francisco and Mount Sinai School of Medicine have used a Drosophila cancer model to identify small molecule kinase inhibitors that target a discrete spectrum of kinases. 1 The...
BioCentury | Feb 19, 2009
Targets & Mechanisms

Beta-blocking wounds

Researchers at the University of California, Davis think they may have identified a new indication for β-blockers: wound healing. 1 Although the safety profile of the drugs in cardiovascular disorders provides an incentive to repurpose...
Items per page:
1 - 3 of 3